Lehnartz, E. : Chemische Physiology, p. 516. Elfte Auflage Verlag Springer , Berlin, Goettingen, Heidelberg, 1959.
2.
Wright, S., et al., Applied Physiology, Ed. 9, Fourth impression . Oxford Medical Publications, London, 1956.
3.
Gomori, G.: Microtechnical demonstration of phosphatase in tissue sections. Proc. Soc. Exper. Biol. &Med., 42: 23, 1939.
4.
Gomori, G.: The distribution of phosphatase in normal organs and tissues. J. Cell. & Comp. Physiol., 17: 71, 1941.
5.
Gomori, G.: Distribution of acid phosphatase in the tissues under normal and under pathologic conditions. Arch. Path., 32: 189, 1941.
6.
Gomori, G.: Histochemical demonstration of sites of phosphamidase activity. Proc. Soc. Exper. Biol. &Med., 69: 407, 1948.
7.
Gomori, G.: Histochemical demonstration between esterases. Proc. Soc. Exper. Biol. &Med., 67: 4, 1948.
8.
Gomori, G.: Histochemical specificity of phosphatases. Proc. Soc. Exper. Biol. &Med., 70: 7, 1949.
9.
Gomori, G.: Further studies on the histochemical specificity of phosphatases. Proc. Soc. Exper. Biol. &Med., 72: 449, 1949.
10.
Gomori, G.: An improved histochemical technic for acid phosphatase. Stain Tech.,25: 81, 1950.
11.
Gomori, G.: Alkaline phosphatase of cell nuclei, J. Lab. & Clin. Med. , 37: 526, 1951.
12.
Gomori, G.: Microscopic Histochemistry. University of Chicago Press , Chicago, 1952.
13.
Gomori, G.: The complex nature of alkaline phosphatase. Biochim. et Biophys. Acta, 8: 162, 1952.
14.
Gomori, G.: Histochemistry of human esterases. J. Histochem.,3: 479, 1955.
15.
Gomori, G., AND Benditt, E.P.: Precipitation of calcium phosphate in the histochemical method for phosphatase . J. Histochem.,1: 114, 1953.
16.
Reis, J.L.: The specificity of phosphamonoesterases in human tissues. Biochem. J., 48: 548, 1951.
17.
Ratnoff, O.D. , AND Donaldson, V.H.: Physiologic and pathologic effects of increased fibrinolytic activity in man with notes on the effects of exercise and certain inhibitors on fibrinolysis. Am. J. Cardiol., 6: 378, 1960.
18.
Cannon, W.B.: The Way of an Investigator. A Scientist's Experiences in the Medical Research . W. W. Norton & Co., Inc., New York, 1945.
19.
VON BRUECKE, E. W.: cited by No. 17.
20.
Ambrus, J.L. , Ambrus, C.M., Sokal, J.E., Markus, G., Bach, N., Stutzman, L., Razis, D., Ross, C.A., Smith, B.H., Rekate, A.C., Collins, G.L., Kline, D.L., AND Fishman, J.B.: Clinical pharmacology of various types of fibrinolytic enzyme preparations . Am. J. Cardiol., 6: 462, 1960.
21.
Morgagni, J.B. : De Sedibus et Causis Morborum per Anatomen Indagatis, Ed. 2. 1761.
22.
Hunter, J.: In Lectures on the Principles of Surgery, edited by J. F. Palmer, Vol. 1, Longmans, Green, London, 1835.
23.
Hunter, J.: Treatise on the Blood, Inflammation, and Gunshot Wounds, p. 575. G. Nicoll, London. 1794.
24.
Denis, P.S.: Essai sur l'Application de la Chimie a l'Etude Physiologique du Sang de l'Homme . Becket, Paris, 1838.
25.
ZIMMERMANN. Cited by S. Sherry and N. Alkj aersig,
26.
Green, G.R. : Note on action of sodium chloride in dissolving fibrin. J. Physiol.,8: 372, 1887.
27.
Denys, P.S. , AND De Marrbaix , H.: Le peptonisotons provoquees pas le chloroforme . Cellule,5: 197, 1889.
28.
Dastre, A.: Fibrinolyse dans le sang. Arch physiol. norm et path.,25: 601, 1893.
29.
Arthur, M., AND Pages, C.: Nouvelle theorie chimique de la coagulation due sang. Arch. physiol. norm. et path.,2: 739, 1890.
30.
Delezene, C. , AND Pozerski, E.: Action du serum sanguin su la gelatine en presence du chloroforme. Compt. rend. Soc. de Biol., 55: 327, 1903.
31.
Hedin, S.G. : On the presence of a proteolytic enzyme in the normal serum of the ox. J. Physiol., 30: 195, 1903.
32.
Opie, E.L., AND Barker, B.I.: Leucoprotease and anti-leucoprotease of mammals and of birds. J. Exper. Med., 9: 207, 1907.
Yudin, S.S. : La transfusion du sang de cadavie aux êtres humains. Presse méd.,44: 68, 1936.
44.
Macfarlane, R.G.: Fibrinolysis following operation. Lancet, 1: 10, 1937.
45.
Macfarlane, R.G.: Human fibrin as a dressing for burns. Brit. M. J.,2: 541, 1943.
46.
Macfarlane, R.G.: The action of soya-bean trypsin inhibitor as an antithromboplasmin in blood coagulation. J. Physiol. , 106: 104, 1947.
47.
Macfarlane, R.G., AND Pilling, J.: Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood. Lancet, 2: 562, 1946.
48.
Macfarlane, R.G. AND Biggs, R.: Observations on fibrinolysis: Spontaneous activity associated with surgical operations. Trauma, etc., Lancet, 2: 862, 1946.
49.
Macfarlane, R.G. AND Pilling, J.: Anticoagulant action of soya-bean trypsin-inhibitor . Lancet, 1: 888, 1946.
50.
Macfarlane, R.G. AND Pilling, J.: Fibrinolytic activity of normal urine. Nature (London), 159: 779, 1947.
51.
Macfarlane, R.G., AND Biggs, R.: Fibrinolysin—Its mechanism and significance . Blood J. Hematol.,10: 1167, 1948 .
52.
Imperati, L. : Rif. med.,53: 1694, 1937 .
53.
Latner, A.C. : Communication to Physiological Society, London. 1946.
54.
Selye, H.: The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol., 6: 117, 1946.
55.
Milstone, H. : A factor in normal human blood which participates in streptococcal fibrinolysis. J. Immunol., 42: 109, 1941.
56.
Kaplan, M.H. : Nature and the role of lytic factors in hemolytic streptococcal fibrinolysis, Proc. Soc. Exper. Biol. &Med., 57: 40, 1944.
57.
Kaplan, M.H. : Dissimilarity of serum protease and trypsin as indicated by the separate specificities of their kinases, fibrinolysin, and enterokinase. J. Clin. Invest., 25: 331, 1946.
58.
Christensen, L.R.: Streptococcal fibrinolysins: A proteolytic reaction due to a serum enzyme activated by steptococcal fibrinolysin. J. Gen. Physiol., 28: 363, 1945.
59.
Christensen, L.R., AND Macleod, C.M.: Proteolytic enzyme of serum: characterization, activation, and reaction with inhibitors. J. Gen. Physiol. , 28: 559, 1945.
60.
Smith, O.W. , AND Smith, G.V.: A fibrinolytic enzyme in menstruation and late pregnancy toxemia. Science, 102: 253, 1945 .
61.
Von Kaulla, K.N.: Betrachtung zur postnarkotischen Fibrinolyse . Schweiz. med. Wochnschr.,77: 313, 1947.
62.
WILSON, J. R., AND MUNNEL E. R.: Cited by Christensen and MacLeod. 59
63.
Halse, T.: Dissertasion on fibrinolysis at theUniversity of Basel . Cited by Christensen and MacLeod,59 1948.
64.
Berg, St P.: Klin. Wchnschr.,28: 29, 507, 1950.
65.
Von Kaulla, K.N. : Gibt es Wege zur therapeutischen Verwertung der Fibrinolyse? Wien. Zschr. Inn. Med., 329, 1952.
66.
Tagnon, H.J. : Significance of fibrinolysin in the mechanism of coagulation of blood. J. Lab. & Clin. Med., 27: 1119, 1942.
67.
Tagnon, H.J. ; Davidson, C.S., AND Taylor, F.H.L.: Coagulation defect in hemophilia; a comparison of the proteolytic activity of chloroform preparations of hemophile and normal plasma. J. Clin. Invest., 22: 126, 1943.
68.
Tagnon, H.J. , Levenson, S.M., Davidson , C.S., AND Taylor, F.M.L.: Occurrence of fibrinolysis in shock, with observations on prothrombin time and plasma fibrinogen during hemorrhagic shock. Am. J. M. Sc.,211: 88, 1946.
69.
Tagnon, H.J. , AND Palade, G.E.: Activation of proplasmin by factors from mammalian tissues. J. Clin. Invest., 29: 317, 1950.
70.
Tagnon, H.J. AND Soulies, J.P.: Anticoagulant action of the trypsin inhibitor from soya-bean flour. Proc. Soc. Exper. Biol. &Med., 61: 440, 1946.
71.
Tagnon, H.J. AND Petermann, M.L.: Proplasmin activator from mammalian tissue . J. Clin. Invest., 28: 814, 1949.
72.
Tagnon, H.J. , Whitmore, W.F., AND Schulman , N.R.: Fibrinolysis in metastatic cancer of the prostate. Cancer, 5: 9, 1952.
73.
Tagnon, H.J. , Whitmore, W.F., Schulman , N.R., AND Kranitz, S.C.: The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate . Cancer , 6: 63, 1953.
74.
Tagnon, H.J. , Whitmore, W.F., Schulman , N.R., AND Kranitz, S.C.: The hemorrhagic syndrome of metastatic prostatic cancer and its treatment. J. Clin. Invest., 31: 666, 1952.
75.
Schulman, N.R. , AND Tagnon, H.J.: Proteolytic activity determined with a substrate tagged with radioactive iodine. J. Biol. Chem., 186: 69, 1950.
76.
Grossi, C.E. , AND Cliffton, E.E.: Clinical use of human fibrinolysin and streptokinase in thromboembolic diseases . (Hematology Study Section, Conference on Thrombolytic Agents, Chicago, Illinois), pp. 222-27, 1960.
77.
Ambrus, J.L. : Fibrinolytic agents in the therapy of thrombolytic disorders. (Hematology Study Section, Conference on Thrombolytic Agents, Chicago, Illinois), pp. 200-13, 1960.
78.
Valentine, W.N. AND Beck, W.S.: Biochemical studies on leukocytes. I. Phosphatase activity in health, leukocytosis, and myelocytic leukemia. J. Lab. & Clin. Med., 38: 39, 1951.
79.
Beck, W.S., AND Valentine, W.N.: Biochemical studies on leukocytes. II. Phosphatase activity in thrombolymphocytic leukemia, acute leukemia, miscellaneous hematologic conditions. J. Lab. & Clin. Med., 38: 245, 1951.
80.
Valentine, W.N., Beck, W.S., Follette , J., Mills, H., AND Lawrence, J.S.: Biochemical studies in chronic myelocytic leukemia, polycythemia vera, and other ideopathic myeloproliferative disorders . Blood, 7: 959, 1952.
81.
Follette, J.H. , Valentine, W.N., AND Lawrence , J.S.: The beta-glucuronidase content of human leukocytes in health and in disease. J. Lab. & Clin. Med., 40: 825, 1952.
82.
Valentine, W.N., Beck, W.S., Follette , J.H., Mills, H., AND Lawrence, J.S.: Biochemical studies in chronic myelocytic leukemia, polycythemia vera, and other ideopathic myeloproliferative disorders . Blood, 7: 959, 1952.
83.
Valentine, W.N., Follette, J.H., Hardin , E.B., Beck, W.S., AND Lawrence , J.S.: Studies on leukocyte alkaline phosphatase activity; relation to stress and pituitary-adrenal activity . J. Lab. & Clin. Med., 44: 219, 1954.
84.
Follette, J.H. , Valentine, W.N., AND Reynolds , J.: A comparison of human leukocyte phosphatase activity towards sodium beta-glycerophosphate, adenosine S-phosphate, and glucose-phosphate. Blood, 14: 415, 1959.
85.
Valentine, W.N.: The biochemistry and enzymatic activities of leukocytes in health and disease. Progr. Hemat.,1: 293, 1956.
86.
Behrendt, H. : Phosphatase activity of human erythrocytes. Proc. Soc. Exper. Biol. &Med., 54: 268, 1943.
Roche, J., AND Bullinger, E.: The phosphatase system of erythrocytes. J. pharm. & chim.,1: 617, 1941.
90.
Roche, J., Thoac, W.V., AND Boudoin, J.: Acid phosphatases of red blood cells. Compt. rend. Acad. sc.,215: 386, 1942.
91.
Woodard, H.Q. , Twombly, G.H., AND Coley, B.: A study of the serum phosphatase in bone disease. J. Clin. Invest., 15: 193, 1936.
92.
Woodard, H.Q. : A modification of the Bodansky method for the determination of inorganic phosphate. J. Lab. & Clin. Med., 22: 1287, 1937.
93.
Woodard, H.Q. , AND Grover, L.F.: Serum phosphatase in the lymphomatoid diseases . J. Clin. Invest., 19: 1, 1940.
94.
Woodard, H.Q. , AND Kenney, J.M.: The relation of phosphatase activity in bone tumors to the deposition of radioactive phosphorus. Am. J. Roentgenol., 47: 227, 1942.
95.
Woodard, H.Q. : Acid and alkaline glycerophosphatase in tissue and serum. Cancer Res., 2: 497, 1942.
96.
Woodard, H.Q. : The phosphatases of human erythrocytes. Blood, 5: 660, 1950.
97.
King, E.G., Wood, E.G., AND Delory, G.E.: Acid phosphatase of the red cells. Biochem. J., 39: 24, 1945.
98.
Gutman, A.B. , AND Gutman, E.B.: An "acid" phosphatase occurring in the serum of patients with metastasizing carcinoma of the prostate gland . J. Clin. Invest., 17: 471, 1938.
99.
Gutman, A.B. , AND Gutman, E.B.: "Acid" phosphatase activity of the serum of normal human subjects. Proc. Soc. Exper. Biol. &Med. , 38: 470, 1938.
100.
Gutman, A.B. , AND Gutman, E.B.: "Acid" phosphatase and functional activity of the prostate (man) and preputial gland (rat). Proc. Soc. Exper. Biol. &Med. , 39: 529, 1938.
101.
Gutman, A.B. , Gutman, E.B., AND Roben-Son , J.N.: Determination of serum "acid" phosphatase activity in differentiating skeletal metastases secondary to prostatic carcinoma from Paget's disease of the bone . Am. J. Cancer, 38: 103, 1940.
102.
Gutman, E.B. , Sproul, E.E., AND Gutman, A.B.: Significance of increased phosphatase activity of bone at the site of osteoplastic metastases secondary to carcinoma of the prostate gland, Am. J. Cancer , 28: 485, 1936.
103.
Gutman E.B. , And Gutman, A.B.: Proc. Soc. Exper. Biol. & Med.,47: 513, 1941.
104.
Wachstein, M.: Alkaline phosphatase activity in blood and bone-marrow cells. J. Lab. & Clin. Med., 31: 1, 1946.
105.
Dalgaard, J.B.: Mordish. Medicin,40: 1767, 1948 .
106.
Kerppola, W.: Observations on the phosphatase content of blood and bone marrow cells in normal and pathologic hemopoiesis. Blood, 6: 454, 1951,
107.
Fell, H.B. , AND Donielli, J.F.: Brit. J. Exper. Path., 24: 196, 1943.
Ratnoff, O.D. : Studies on a proteolytic enzyme in human plasma. IV. The rate of lysis of plasma clots in normal and diseased individuals, with particular reference to hepatic disease. Bull. Johns Hopkins Hosp., 83: 29, 1949.
111.
Cliffton, E.E.: Variations in proteolytic and antiproteolytic reactions of serum. J. Lab. & Clin. Med., 39: 105, 1952.
112.
Sahli, W.: Ueber das Vorkommen von pepsin und Trypsin in normalen menschlichen Harn. Arch. f. d. ges. Physiol.,36: 209, 1885.
113.
Gehrig, F. : Ueber Fermente in Harn. Arch. ges. Physiol.,38: 35, 1885-1886.
114.
Bendersky, J.: Ueber die Ausscheidung der Verdauungs fermente (pepsin, trypsin, ptyalin) aus dem Organismus bei Gesunden und Kranken Menschen . Arch. path. Anat.,121: 554, 1890.
115.
Gruetzner, P.: Ueber Fermente in Harn. Deutsche med. Wchnschr.,17: 10, 1891.
Baumann, J. : Experimentelle Untersuchungen zur Frage der "Trypsinvergiftung," bei Akcuter Pancreas Nekroce nebst Angabe einer sehr empfindlichen, exakten Methode zur quantitativen Trypsinbestimmung. Ztschr. ges. exper. Med., 91: 120, 1933.
118.
Soulier, J.P. , AND Koupfrnik, C.: Con-stance de la fibrinolyse au cours du choeacetylcholinique. Sang,19: 362, 1948.
119.
Meneghini, P., AND Piccinini, F.: Attivazione fibrinolitica del sangue da acido e da alcool nicotinico. Arch. Maragliano Pat. Clin.,14: 69, 1958.
120.
Weiner, M. , De Crinis, K., Redisch , W., AND Steele, J.M.: Influence of some vasoactive drugs on fibrinolytic activity. Circulation , 19: 845, 1959.
121.
Della Santa, R.: Rieme Journee de Therapeutique Clinique, p. 307, 1949.
122.
Kwaan, H.C. , Lo, R. AND McFadzean, A.J.S.: On the inhibition of plasma fibrinolytic activity by exercised ischaemic muscles . Clin. Sc.,17: 361, 1958.
123.
Kwaan, H.C. , AND McFadzean, A.J.S.: On plasma fibrinolytic activity induced by ischaemia. Clin. Sc.,15: 245, 1956.
124.
Kwaan, H.C. , Lo, R., AND McFadzean, A.J.S.: On the production of plasma fibrinolytic activity within veins. Clin. Sc.,16: 241, 1957.
125.
Kwaan, H.C. , Lo, R. AND McFadzean, A.J.S.: The production of plasma fibrinolytic activity in vivo by serotonin (5-hydroxytryptomine) creatinine sulphate. Clin. Sc.,16: 255, 1957.
126.
Jacoby, M. : Ueber die Beziehungen der Leber und Blutveraenderungen bei Phosphorvergiftung zur Autolyse. Ztschr. physiol. Chem.,30: 174, 1900.
127.
Laborit, H. (in collaboration with M. Cara, P. Jouasset, C. Duchesne , and G. Laborit): Stress and Cellular Function, pp. 178, 48, 49 (in order of citation). J. B. Lippincott Company, Philadelphia, 1959.
128.
Grenell: Cited by Loget, P.: Colloque el' eletrophysiologie du CNRS, pp. 273-293. Paris , 1949.
Andrejew, Q., Ducet, G., Louw , G., AND Rosenberg, A.G.: C. Roy. Soc. Biol., 150: 484, 509, 1956.
131.
Bragdon, D.E. , AND McManus, J.F.A.: Histochemical distribution of 5-nucleotidase in snake tissues: Presence of 5-nucleotidase and absence of alkaline phosphomonoesterase in venom glands of the rattlesnake. Quart. J. Micr. Sc., 93; 391, 1952.
Fabbri, W. : Considerazioni sul fenomeno della fibrinolisi dopo shock acetilcolinico ed altri trattamenti shockterapici. Riv. Pat. Nerv. Ment.77: 671, 1956.
134.
Hoff, F.: Fieber, unspezifische Abwehrvorgaenge, unspezifische therapie, p. 79. Georg Thieme , Stuttgart, 1957.
135.
Lewis, J.H. , AND Ferguson, J.H.: Studies on a proteolytic enzyme system of the blood. V. Activation of profibrinolysin by trypsin. Am. J. Physiol., 170: 636, 1952.
136.
Rocha E.Silva, M., Andrade, S.O., AND Teixeira, R.M.: Fibrinolysis in peptone and anaphylactic shock in dog. Natur,157: 801, 1946.
137.
Von Kaulla, K.N. .: Intravenous protein-free pyrogens—A most powerful fibrinolytic agent in man. Circulation, 17:187, 1958.
138.
Olesen, E.S. : Fibrinolytic activity derived from guinea pig serum by peptone. Acta physiol. scandinav.,41: 187, 1957.
139.
Olesen, E.S. : Peptone activation of a serum fibrinolytic system. Acta pharmacol.,15: 197, 1959.
140.
Olesen, E.S. : Effect of acid polysaccharides on the fibrinolytic system in guinea pig serum . Acta pharmacol.,15: 307, 1959.
141.
Olesen, E.S. : Effect of anionic polyelectrolytes on the fibrinolytic system of guinea pig serum. Acta pharmacol.,16: 38, 1959.
142.
Kline, L.D.: Critique (comments), p. 253. The Hematology Study Section, Conference on Thrombolytic Agents, Chicago, Illinois, 1960.
143.
Astrup, T.: Critique (comments), p. 246. The Hematology Study Section, Chicago, 1960.
144.
Astrup, T.: Activation of plasminogen, p. 40. The Hematology Study Section, Chicago, 1960.
145.
Von Kaulla, K.N. : Fibrinolysis in man induced by nonenzymatic, nonpyrogenic drug. p. 94. The Hematology Study Section, Chicago, 1960.
146.
Von Kaulla, K.N., AND Schmeck, S.A.: Activation of human fibrinolytic system by drugs and neurologic procedures, Clin. Res., 9: 67, 1961.
147.
Markus, G. , AND Ambrus, C.M.: Characterization of enzymes resulting from plasminogen activation. Fed. Proc., 28: 981959.
148.
Markus, G. , AND Ambrus, C.M.: On the formation of different types of plasmins by streptokinase activation. J. Biol. Chem. , 235: 1673, 1960.
149.
Deane, H.W., Barrnett, R.G., AND Selig-Man, A.M.: Enzymes, Vol. VII. Part I: Histochemical Methods for the Demonstration of Enzymatic Activity, pp. 115-116, Verlag G. Fischer, Stuttgart, 1960 .
150.
Verzar, F.: Adrenal cortex and carbohydrate phosphorylation. In Colloquia on Endocrinology, London, pp. 152-165. J. & A. Churchill, Ltd., London, 1953.
151.
Verzar, F.Cited by Lehnartz,1 p. 299.
152.
Misirlioglu, Y.I., AND Lillehei , C.W.: Severe gastrointestinal hemorrhage and perforation as complications of open cardiac surgery by extracorporeal circulation by direct vision utilizing a pumpoxygenator ; Its etiology and pathogenesis. In press.
153.
MAGNUS. Cited by Lehnartz,1 p. 278.
154.
Johnson, J.F. : Paper presented at symposium on blood. Wayne State University, Detroit, Michigan , January 18, 1957.
155.
Johnson, J.F. : Paper cited in Med. Sc.1: 33, 1957.
Alkjaersig, N., Fletcher, A.P., AND Sherry, S.: ε-Aminocaproicc aid: An inhibitor of plasminogen activation. J. Biol. Chem. , 234: 832, 1959 .
163.
Sherry, S. , Fletcher, A.P., Alkjaersig , N., AND Sawyer, W.D.: ε-Aminocaproic acid: A potent antifibrinolytic agent. Tr. A. Am. Physicians,72: 62, 1959.
164.
Lehnarzt, E. : Chemische Physiology, p. 259. Elfte Auflage Verlag Springer , Berlin, Goettingen, Heidelberg, 1959.
165.
Beaufay, H. , Hess, H.G., Berthet , G., AND De Duve, C.: V. Influence du divers agents sur l'activite et stabilite de la glucose-6-phosphatase, Bull. Soc. Chim. Biol., 36: 1539, 1954.
166.
Gray, H.: Anatomy of the Human Body, Ed. 27. Edited by C. M. Goss.Lea & Febiger , Philadelphia, 1959.
167.
Sapyer, C.: Lecture given on Hypophysis and Hypothalamus atthe University of Minnesota, February 16, 1961.
168.
Bergmann, W., AND Scharrer, E.: The site of origin of the hormones of the posterior pituitary. Am. Scientist, 39: 255, 1951.
169.
Leaf, A.: "Diabetes Insipidus" Cited in Astwood, E. B.: Clinical Endocrinology, Vol. I, p. 73. Grune & Stratton, New York, 1960.
170.
Ruch, T.C., AND Fulton, G.F.: Medical Physiology and Biophysics, Ed. 18. W. B. Saunders Co., Philadelphia , 1960.
171.
Flaschen-Traeger, B. AND E. Lehnarzt(Hrsgh.): PhysiologischeChemie, Vol. IV, Springer , Berlin, Goettingen , and Heidelberg, 1956.
172.
Bergmann, M.: A classification of proteolytic enzymes, Advance Enzymol.,2: 49, 1942.
173.
Dixon, M. AND E.C. Webb: Enzymes, Longmans, Green, London , 1958.
Lang, K. AND E. Lehnarzt (in collaboration with G. Siebert, 10th ed.): originally by Hoppe-Seyler, Thierfelder: Handbuch der Physiologisch und Pathologisch-Chemischen Analyse, Berlin, Goettingen, and Heidelberg, 1953.